Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top Medtech Lobbyist Doubts Legislative Repercussions Of New Netflix Documentary

Executive Summary

AdvaMed's top lobbyist says a new documentary critical of the medical device industry and US FDA's device review pathways is unlikely to result in Congressional action. However, the group is talking to members on Capitol Hill to make sure they fully understand the context within which devices are reviewed and marketed.

Advertisement

Related Content

Into 2019: Digital Leads US Policy Innovations, But Public Medtech Scrutiny Grows
Device Sector Braces For Investigative Stories Critical Of Industry
Investigative Press Flocks To EU Medtech Regulatory Conference: But Why?
Industry, US FDA Defend Innovation As A Force For Good
Public Interest Groups Will Leverage ‘Bleeding Edge’ Lessons To Push For Device Safety Changes
New Safety Framework Mixes Current Efforts, New Investments At US FDA

Topics

Advertisement
UsernamePublicRestriction

Register

MT123191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel